Hepatocellular carcinoma with extrahepatic metastasis: Are there still candidates for transarterial chemoembolization as an initial treatment?

BACKGROUND AND AIM: Currently, sorafenib is indicated for hepatocellular carcinoma (HCC) with extrahepatic metastasis (EHM), and many other systemic agents are becoming available. However, a few HCC patients with EHM still undergo transarterial chemoembolization (TACE) for intrahepatic tumor control...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jihye, Sinn, Dong-Hyun, Choi, Moon Seok, Kang, Wonseok, Gwak, Geum-Youn, Paik, Yong-Han, Lee, Joon Hyeok, Koh, Kwang Cheol, Paik, Seung Woon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405107/
https://www.ncbi.nlm.nih.gov/pubmed/30845192
http://dx.doi.org/10.1371/journal.pone.0213547

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405107/
https://www.ncbi.nlm.nih.gov/pubmed/30845192
http://dx.doi.org/10.1371/journal.pone.0213547

Ejemplares similares